Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related IRIS

Cengiz Bayram, Ali Fettah, Nese Yarali, Abdurrahman Kara, Fatih Mehmet Azik, Betül Tavil, Bahattin Tunc
  • Cengiz Bayram
    Affiliation not present
  • Ali Fettah
    Affiliation not present
  • Abdurrahman Kara
    Affiliation not present
  • Fatih Mehmet Azik
    Affiliation not present
  • Betül Tavil
    Affiliation not present
  • Bahattin Tunc
    Affiliation not present

Abstract

Hepatosplenic candidiasis (HSC) is a form of invasive fungal infection that occurs most commonly in patients with acute leukemia treated with chemotherapy and requires protracted antifungal therapy. Immune reconstitution inflammatory syndrome (IRIS) is best characterized as a dysregulated inflammatory responses triggered by rapid resolution of immunosuppression.

We present a child diagnosed with standard-risk precursor B cell-acute lymphoblastic leukemia who developed HSC and Candida-related IRIS during recovery of neutropenia associated with induction chemotherapy. Addition of corticosteroid therapy to antifungal treatment is associated with the resolution of the clinical symptoms and laboratory findings

Full Text:

PDF
HTML
Submitted: 2014-06-13 09:32:55
Published: 2012-03-13 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
476

Views:
PDF
128
HTML
909

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006] is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.
 
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185